Beneficial effects of co-enzyme Q10 and rosiglitazone in fructose-induced metabolic syndrome in rats
In conclusion, the present study proves the benefits of co-supplementation of CoQ and Rosi in a fructose-induced model of insulin resistance.
Source: Bulletin of Faculty of Pharmacy, Cairo University - Category: Drugs & Pharmacology Source Type: research
More News: Avandia | Cholesterol | Drugs & Pharmacology | Insulin | Laboratory Medicine | Liver | Metabolic Syndrome | Nutrition | Pancreas | Study | Urology & Nephrology